
EMA recommends marketing authorization for donanemab (Kisunla)
This announcement reverses an earlier recommendation made by the EMA regarding donanemab as a treatment for the treatment of early symptomatic Alzheimer's disease in adults.
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
This announcement reverses an earlier recommendation made by the EMA regarding donanemab as a treatment for the treatment of early symptomatic Alzheimer's disease in adults.
The 78th World Health Assembly has been a whirlwind week for ADI as, after 18-months of advocacy, the World Health Assembly has agreed to extend the Global Action Plan on the Public Health Response to Dementia by 6-years, to 2031.
AD-RIDDLE, funded by the Innovative Health Initiative, a European Union public privative partnership, brings together academics, healthcare providers, pharmaceutical companies, regulatory bodies to develop tools and resources for healthcare providers.
ADI calls for lived experience to be central to innovation in the field of dementia diagnostics, treatment and care. In her short interview with Novartis, Paola Barbarino highlights key areas which innovators must consider when developing their products and service, from inception, to testing and ultimately bringing them to market; and reminds us not to forget that simple innovative changes can lead to great impact.
Diego Aguilar, Regional Director for the Americas gives his insights on the recent ADI members meeting for Latin America and the Caribbean, held in San Juan, Puerto Rico in early December 2023.
DY Suharya, Director of ADI Asia Pacific, and Shyh Poh Teo, Director of Demensia Brunei, reflect on the 2023 Asia Pacific Regional Conference as co-organisers of the event.
This November, African regional members from across the continent including Botswana, Burundi, Cameroon, Ethiopia, France, Ghana, Kenya, Madagascar, Mauritius, Nigeria, Sénégal, South Africa, Uganda and Zimbabwe, convened in…
Paul Bebbington and Elizabeth Kuipers, two academics whose lives are now impacted by Paul’s diagnosis of Alzheimer’s, offer brave accounts of the day-to-day experiences of living with dementia and being a care provider in an initiative to reduce stigma.
Centre for Applied Dementia Studies at the University of Bradford becomes the first institution in Europe to receive the ADI Accreditation, marking a historic milestone for University of Bradford and ADI
In November 2023, the ECLAC policy leaders convened in Santiago, Chile, to commemorate the 10th Anniversary of the Montevideo Consensus. Regional Director for the Americas, Diego Aguilar reflects on this meeting, and the importance of funded National Dementia Plans to ensure social protection for the ageing population of the Latin American and Caribbean regions.